David B. Jackson

Heidelberg, BW 69115, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach.

Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach.

Journal: Journal of cancer research and clinical oncology

Published: December 07, 2023

Rewiring Drug Research and Development through Human Data-Driven Discovery (HD3).

Rewiring Drug Research and Development through Human Data-Driven Discovery (HD3).

Journal: Pharmaceutics

Published: May 11, 2023

Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide.

Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide.

Journal: Cancers

Published: December 19, 2022

Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms.

Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms.

Journal: Frontiers in molecular medicine

Published: September 02, 2022

The COVID-19 explorer-An integrated, whole patient knowledge model of COVID-19 disease.

The COVID-19 explorer-An integrated, whole patient knowledge model of COVID-19 disease.

Journal: Frontiers in molecular medicine

Published: September 02, 2022

Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reports.

Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reports.

Journal: CPT: pharmacometrics & systems pharmacology

Published: September 30, 2021

Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors.

Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors.

Journal: Clinical and translational science

Published: August 03, 2021

A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development.

A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development.

Journal: Clinical and translational science

Published: August 02, 2021

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide.

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide.

Journal: International journal of molecular sciences

Published: March 30, 2020

Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients.

Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients.

Journal: Cancers

Published: March 16, 2020

Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting.

Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting.

Journal: Clinical pharmacology and therapeutics

Published: September 20, 2019

Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar.

Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 16, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026